Keyphrases
Parkinsonian Gait
100%
Spatiotemporal Scaling
100%
Gait
100%
Progressive Model
100%
Gait Disorders
100%
Parkinson's Disease Model
100%
Gait Deficits
50%
Nonhuman Primate
50%
Parkinsonian State
50%
Stance Phase
25%
Patients with Parkinson's Disease
25%
Primate Model
25%
Parkinsonism
25%
Swing Phase
25%
Stride Length
25%
Pathophysiology
25%
Parkinsonian
25%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
25%
Temporal Features
25%
Moderate to Severe
25%
Motor Signs
25%
Volitional
25%
Effective Therapy
25%
Gait Pattern
25%
Intra-subject
25%
Spatial Features
25%
Treatment Level
25%
Moderate Stage
25%
Mild Stage
25%
Severe Stage
25%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Preclinical Study
66%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
33%
Parkinsonism
33%
Pathophysiology
33%
Neuroscience
Parkinson's Disease
100%
Tetrahydropyridine
33%
Neurophysiology
33%
Parkinsonism
33%